Oesterle S N, Bittl J A, Leon M B, Hamburger J, Tcheng J E, Litvack F, Margolis J, Gilmore P, Madsen R, Holmes D, Moses J, Cohen H, King S, Brinker J, Hale T, Geraci D J, Kerker W J, Popma J
Department of Medicine, Stanford University Medical Center, California 94305, USA.
Cathet Cardiovasc Diagn. 1998 Jun;44(2):235-43. doi: 10.1002/(sici)1097-0304(199806)44:2<235::aid-ccd23>3.0.co;2-k.
The Prima laser guidewire system (Spectranectics Corp., Colorado Springs, CO) consists of an 0.018" hypotube containing a bundle of 45-microm optical fibers coupled to a pulsed excimer laser operating at a tip fluence of 60 ml/mm2 and a repetition rate ranging from 25-40 Hz. This laser guidewire was specifically designed to cross total occlusions refractory to passage with conventional wires. The Prima wire was evaluated in a feasibility study at 15 U.S. centers. Following failure to cross a total occlusion with approved guidewires, the Prima wire was utilized in 179 patients. Average age of subjects was 61 yr. Lesion locations included left anterior descending (36%), right (45%), and circumflex (19%) coronary arteries. Mean angiographic age of total occlusions was 70 wk (range, 2-1,020 wk, median, 14 wk). The use of the Prima wire either solely or in combination with conventional guidewires resulted in successful crossing in 61% of these previously impenetrable occlusions. Failure of the device was commonly related to length of the occlusion and tortuosity along the occluded pathway. Major complications included myocardial infarction in 7 patients (3.9%), tamponade in 3 (1.7%), and death in 2 (1.1%). This "learning phase" pilot study confirmed the feasibility of a laser guidewire in chronic total occlusions that are resistant to passage of conventional guidewires. An extended registry at these investigative sites is planned.
Prima激光导丝系统(Spectranectics公司,科罗拉多州斯普林斯)由一根0.018英寸的海波管组成,其中包含一束45微米的光纤,与一台脉冲准分子激光器相连,该激光器在尖端的能量密度为60 mJ/mm²,重复频率范围为25-40 Hz。这种激光导丝专门设计用于穿过传统导丝难以通过的完全闭塞病变。在美国15个中心进行了一项可行性研究,对Prima导丝进行了评估。在用已批准的导丝未能穿过完全闭塞病变后,179例患者使用了Prima导丝。受试者的平均年龄为61岁。病变部位包括左前降支(36%)、右冠状动脉(45%)和回旋支(19%)。完全闭塞病变的平均血管造影显示时间为70周(范围为2-1020周,中位数为14周)。单独使用或与传统导丝联合使用Prima导丝,使这些先前难以穿透的闭塞病变中有61%成功穿过。该设备的失败通常与闭塞的长度和闭塞路径的迂曲程度有关。主要并发症包括7例患者发生心肌梗死(3.9%),3例发生心包填塞(1.7%),2例死亡(1.1%)。这项“学习阶段”的初步研究证实了激光导丝用于常规导丝难以穿过的慢性完全闭塞病变的可行性。计划在这些研究地点进行一项扩大的注册研究。